FDA inspection
Rotech Healthcare, Inc. d/b/a CPO2: FDA inspection ending Oct 25, 1999
FDA inspection 2060 · No Action Indicated (NAI) · Lancaster, PA
Key facts
| Inspection ID | 2060 |
|---|---|
| Firm | Rotech Healthcare, Inc. d/b/a CPO2 |
| FEI number | 1000121578 |
| Address | 1630 Manheim Pike, Suite 3 |
| City | Lancaster |
| State | PA |
| ZIP | 17601-3064 |
| Fiscal year | 2000 |
| Inspection end date | Oct 25, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data